Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacokinetic optimisation of vancomycin therapy

W G Leader1, M H Chandler, M Castiglia

  • 1Department of Clinical Pharmacy, School of Pharmacy, West Virginia, University, Morgantown, USA.

Clinical Pharmacokinetics
|April 1, 1995
PubMed
Summary

Vancomycin serum concentrations lack definitive links to patient outcomes or toxicity. Routine monitoring may only be necessary for specific high-risk patient groups, considering individual pharmacokinetic variability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM-SIAPEC-IAP-SIBioC-SIC-SIF Italian Scientific Societies.

ESMO open·2021
Same author

The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials.

ESMO open·2021
Same author

Immunohistochemical/histochemical double staining method in the study of the columnar metaplasia of the oesophagus.

European journal of histochemistry : EJH·2014
Same author

Predictors of childhood immunization completion in a rural population.

Social science & medicine (1982)·1999
Same author

Persuasive messages. Development of persuasive messages may help increase mothers' compliance of their children's immunization schedule.

Marketing health services·1999
Same author

Stability of high-dose vancomycin and ceftazidime in peritoneal dialysis solutions.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1999

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Infectious Diseases

Background:

  • Vancomycin use has increased, generating extensive pharmacokinetic data.
  • Current data do not definitively link vancomycin serum concentrations to clinical outcomes.
  • Challenges exist in interpreting vancomycin levels due to inconsistent sampling and infusion times.

Purpose of the Study:

  • To review the current understanding of vancomycin pharmacokinetics and dosage adjustments.
  • To evaluate the correlation between vancomycin serum concentrations, clinical outcomes, and adverse effects.
  • To identify specific populations where vancomycin serum concentration monitoring is warranted.

Main Methods:

  • Review of existing literature on vancomycin pharmacokinetics, dosing strategies, and therapeutic drug monitoring.

Related Experiment Videos

  • Analysis of factors influencing vancomycin dose-serum concentration relationships.
  • Evaluation of evidence for vancomycin-associated oto- and nephrotoxicity.

    • Main Results:

    • No definitive correlation established between vancomycin serum concentrations and clinical outcomes.
    • Evidence for vancomycin-induced oto- or nephrotoxicity is circumstantial and may be limited to high-risk groups.
    • Population- or patient-specific pharmacokinetic data improve vancomycin dosing accuracy over standard nomograms.

    Conclusions:

    • Routine vancomycin serum concentration monitoring is controversial due to lack of definitive outcome correlation.
    • Monitoring may be beneficial for specific high-risk populations, including those on concurrent nephrotoxic agents or with fluctuating renal function.
    • Adjusting vancomycin dosages requires careful consideration of patient-specific factors and pharmacokinetic variability.